Plain language summaries in the British Journal of Dermatology: Connecting with patients

British Journal of Dermatology

Volumn 170, Issue 1, 2014, Pages 1-3

  Anstey, A ^a,b  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; PLACEBO;

CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL DECISION MAKING; CUTANEOUS MELANOMA; DERMATOLOGIST; DERMATOLOGY; EDITORIAL; HEALTH EDUCATION; HEALTH HAZARD; HEALTH LITERACY; HUMAN; IMMUNOCHEMOTHERAPY; KNOWLEDGE; LANGUAGE; MEDICAL INFORMATION; METASTATIC MELANOMA; OVERALL SURVIVAL; PATIENT ADVOCACY; PRIMARY TUMOR; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); WIDE EXCISION; PATIENT EDUCATION; PROCEDURES; PUBLICATION;

DERMATOLOGY; HUMANS; LANGUAGE; PATIENT EDUCATION AS TOPIC; PERIODICALS AS TOPIC;

EID: 84892396591     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12760     Document Type: Editorial

References (7)

1. Sasse AD, Sasse EC, Clark LGO, et al,. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma (review). Cochrane Database Syst Rev 2007; 24: CD005413.
2. Sladden MJ, Balch C, Barzilai DA, et al,. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009; 7: CD004835.
3. Singh JA, Wells GA, Christensen R, et al,. Adverse effects of biologics: a network meta-analysis and Cochrane Overview. Cochrane Database Syst Rev 2011; 16: CD008794.
4. Ahmed H, Naik G, Willoughby H, Edwards AGK,. Communicating risk. BMJ 2012; 344: e3996.
5. May C, Montori V, Mair F,. We need minimally disruptive medicine. BMJ 2009; 339: 485-7.
6. Nutbeam D,. Health promotion glossary. Health Promot Int 1998; 13: 349-64.
7. Nutbeam D,. Health literacy as a public goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int 2000; 15: 259-67.